05/06/2024
GPN Vaccines Closes $18M Series B1 Round
Adelaide, Australia, 6th June 2024 – GPN Vaccines is pleased to announce the closing of its oversubscribed Series…
Adelaide, Australia, 6th June 2024 – GPN Vaccines is pleased to announce the closing of its oversubscribed Series…
Adelaide, Australia, 31st January 2023 – GPN Vaccines is pleased to announce the closing of its Series A3…
Adelaide, Australia, 30th June 2020 – Australian biotechnology company GPN Vaccines, which is developing a vaccine against the…
Adelaide, Australia, 18 January 2019 – GPN Vaccines, a vaccine development company focussed on the prevention of diseases caused…